Search results
Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
WSLS Newschannel 10 Roanoke· 5 days agoMore than 10 million older adults have gotten either Pfizer or GSK single-dose shots since early...
US FDA approves Moderna’s RSV vaccine, its second marketed product
KFGO· 4 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 4 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 1 day agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Bronchiolitis: Two French studies demonstrate the effectiveness of nirsevimab to protect infants
Medical Xpress· 7 days agoAfter a 2022–2023 season marked by a severe epidemic of bronchiolitis due to respiratory syncytial ...
Feds plan for smoother access to RSV infant shot
Politico· 6 days agoRSV sends 58,000 to 80,000 children under age 5 to the hospital each year, and severe cases can be fatal. AstraZeneca’s monoclonal antibody shot Beyfortus cuts by about 90 ...
Moderna's RSV Vaccine Approved by FDA
Medscape· 1 day agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations currently on the market for respiratory syncytial virus.
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 3 hours agoPfizer's Abrysvo is one of three new respiratory syncytial virus (RSV) vaccines approved to prevent...
